Hidemi Toyoda

8PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 26, 2025
6-Aminonicotinamide enhances the efficacy of 5-aminolevulinic acid-mediated photodynamic therapy for neuroblastoma.

Satoshi Muramatsu Okamura, Vipin Shankar Chelakkot, Zayar Linn

|Dec 08, 2024
Inotuzumab ozogamicin for relapse prevention in a boy with Down syndrome and relapsed acute lymphoblastic leukemia.

Atsushi Kohso, Hidemi Toyoda, Ryo Hanaki

|Sep 13, 2024
Outcomes in children with first-relapsed acute lymphoblastic leukemia in Japan: Results from JCCG Study JPLSG-ALL-R08.

Junko Yamanaka, Chitose Ogawa, Ayumu Arakawa

|Jan 24, 2024
TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia.

Hideaki Ueki, Chitose Ogawa, Hiroaki Goto

|Sep 14, 2023
Secondary malignancy after carbon ion radiotherapy in a 15-year-old female with Ewing sarcoma.

Eri Ushida, Hidemi Toyoda, Ryo Hanaki

Pageof 2